Best Known Analyst's Ratings for: Opko Health, Inc. (OPK)
- Author: Zachary Reyes Jun 07, 2017,
Jun 07, 2017, 4:13
A Form 4 obtainable for free here shows this insider activity, that was conducted on June 6, 2017 and was filed with the U.S. Security & Exchange Commission. Finally, World Asset Management Inc increased its position in shares of Opko Health by 23.6% in the first quarter. The stock has a market capitalization of $5.99 billion. The company has an Average True Range (ATR) value of 0.27, while a Beta Value of 1.86. (NASDAQ:OPK) opened at 6.29 on Tuesday. The price index is calculated by dividing the current share price by the share price ten months ago. The stock was acquired at an average price of $6.96 per share, for a total transaction of $7,830,000.00.
On Thursday, May 18th, Phillip Md Et Al Frost bought 20,000 shares of Opko Health stock. Both OPKO Health, Inc. (NASDAQ:OPK) traded up 4.52% on Friday, reaching $6.71. "Ultimately, through all this investigation into the company's performance the analyst decides if their stock is a "buy", sell" or hold". The firm has a 50-day moving average of $7.08 and a 200 day moving average of $8.64. The company's market cap is $3.59 Billion, and the average volume is 4.46 Million. Apriem Advsrs reported 0.01% of its portfolio in Opko Health Inc.
Insider Trades for Opko Health, Inc. show that the latest trade was made on 31 May 2017 where Paganelli (John A), the Director completed a transaction type "Buy" in which 5000 shares were traded at a price of $6.17. During the same quarter in the previous year, the company posted ($0.02) earnings per share. Return on Equity (ROE) stands at -2.1% and Return on Investment (ROI) of -0.8 percent. The business had revenue of $296.10 million for the quarter, compared to analyst estimates of $313.36 million. The firm's quarterly revenue was up 1.8% compared to the same quarter a year ago. Equities research analysts forecast that Opko Health Inc. will post ($0.20) EPS for the current year.
OPK has been the topic of a number of recent research reports. If you are accessing this story on another website, it was illegally copied and republished in violation of USA & worldwide copyright & trademark laws. The correct version of this piece of content can be accessed at https://baseballnewssource.com/markets/opko-health-inc-opk-ceo-acquires-771600-00-in-stock-updated/849552.html. Hedge funds and other institutional investors own 22.58% of the company's stock. (NASDAQ:OPK) news were published by: Globenewswire.com which released: "OPKO Health to Announce 2017 First Quarter Financial Results on May 9, 2017" on May 08, 2017. Norges Bank purchased a new stake in Opko Health during the fourth quarter worth $30,421,000. New York-based Geduld E E has invested 0.24% in Opko Health Inc. The stock sank -16.69% last month and is down -32.37 this year.
Several research analysts recently issued reports on the company. The stock was purchased at an average cost of $6.59 per share, for a total transaction of $131,800.00.
Analysts' mean recommendation for Opko Health, Inc. Standpoint Research reissued a "buy" rating and issued a $14.00 price target on shares of Opko Health in a report on Sunday, March 5th. Jefferies Group LLC decreased their price objective on Opko Health from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, March 2nd. Finally, Guggenheim assumed coverage on Opko Health in a report on Tuesday, March 14th. They issued a "buy" rating and a $25.00 target price for the company.
Some buy side analysts are also providing their Analysis on Opko Health, Inc., where 1 analysts have rated the stock as Strong buy, 3 analysts have given a Buy signal, 1 said it's a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. By reviewing stock prices from the stock market history of the company and examining its analysts ratings can give an investment picture with updated information of stock which helps investors to make investing decision.